- Home
- AMLX vs AMBA Comparison
AMLX vs AMBA Comparison
Compare AMLX & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | AMBA |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | 136 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AMLX | AMBA |
|---|---|---|
| Price | $27.68 | $55.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $42.64 | ★ $87.55 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 11-05-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | 37.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | $295,402,000.00 |
| Revenue This Year | N/A | $12.89 |
| Revenue Next Year | N/A | $12.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $10.83 | $48.30 |
| 52 Week High | $41.14 | $96.69 |
Technical Indicators
Market Signals| Indicator | AMLX | AMBA |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 40.20 |
| Support Level | $26.16 | $59.89 |
| Resistance Level | $34.35 | $70.65 |
| Average True Range (ATR) | 1.48 | 3.63 |
| MACD | 0.28 | -0.23 |
| Stochastic Oscillator | 70.80 | 23.55 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About AMBA Ambarella Inc.
Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.